The intra-monocyte pharmacokinetics of imiglucerase suggests a possible personalization of enzyme replacement therapy in patients with GD1 von Berger, Marc G., Berger, Juliette, Vigan, Marie, Pereira, Bruno, Froissart, Roseline, Belmatoug, Nadia, Dalbies, Florence, Masseau, Agathe, Rose, Christian, Serratrice, Christine, Pers, Yves-Maris, Bertschanski, Ivan, Bengherbia, Monia, Bourgne, Céline, Janel, Alexandre, Caillaud, Catherine, Pettazzoni, Magali, Berrahal, Amina, Stirnemann, Jérôme, Mentré, France

Volltext